Donate For Public and Patients Store Search

S001 - Melanoma: The Future is Now

Friday, March 1; 9:00 AM - 12:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Answer patient questions about the War On Melanoma Early Detection Campaign to be released on May, 18 2019
  • Determine which non-invasive technologies for melanoma are (and are not) appropriate for their practice
  • Order the appropriate molecular melanoma tests for the right patient and clinical scenario

Description

Dermatologists must stay abreast of new and evolving apps, devices, molecular and genetic tests, and strategies for melanoma care. Which of these advances are ready for "prime time" and will be truly useful in your practice? Learn about these options before your patients ask. We will describe, explain, and update you on the most promising new methods and technologies available for melanoma. Liberal question and answer periods and panel discussions are included to encourage audience engagement and to ensure exploration of controversial topics.

Disclosures

  • Chen, Suephy C., MD: BioPharmX – O(IP); Dermecular Therapeutics – O(IP); Leo Pharma Inc. – A(H); Phoenix Tissue Repair – O(IP); Trevi Therapeutics – O(IP); Unilever – O(IP);
  • Curiel-Lewandrowski, Clara N., MD: Amgen – I(Grants/Research Funding);
  • Ferris, Laura K., MD, PhD: Abbott Laboratories – I(OB); Amgen – I(OB); Boehringer Ingelheim – I(OB); Castle Biosciences, Inc – C(H), I(OB); Celgene Corporation – I(OB); DermTech International – C(H), I(OB); Eli Lilly and Company – I(OB); Janssen Pharmaceuticals, Inc – C(H); Janssen Research & Development, LLC – I(OB); LEO Pharma, US – I(OB); Medimmune – I(OB); Novartis – A(H), I(OB); Pfizer Inc. – I(OB); Regeneron – I(OB);
  • Gerami, Pedram, MD: Castle Biosciences, Inc – C(H); DermTech International – C(H); Myriad Genetics Inc – C(H);
  • Leachman, Sancy A., MD, PhD: Castle Biosciences, Inc – I(NC); DermDetect – A(NC); Merck & Co., Inc – A(NC); Myriad Genetics Inc – I(NC); OrLucent, Inc. – A(H); Palvella Therapeutics – A(NC); Skin Cancer Free – B(NC); Veriskin – A(NC);
  • Malvehy, Joseph, MD: Cedilp – F(S); Taylor & Francis – O(IP);
  • Rigel, Darrell S., MD: Aclaris Therapeutics, Inc. – C(H); Beiersdorf, Inc. – A(H); Castle Biosciences – A(H), I(Grants/Research Funding); Derm Tech International – A(H), C(H); Ferndale Laboratories, Inc. – C(H); Foamix – SH(SO); LEO Pharma, US – A(H); Myriad Genetics Inc – A(H); Novartis – A(H); Ortho Dermatologics – A(H); Pierre Fabre Dermo-Cosmétique US – A(H); SciBASE – C(H);
  • Swetter, Susan M., MD: no financial relationships exist with commercial interests.
  • Tkaczyk, Eric Robert, MD, PhD: Incyte Corporation – A(Fees);
  • Tschandl, Philipp, MD: no financial relationships exist with commercial interests.
  • Witkowski, Alexander, MD, PhD: no financial relationships exist with commercial interests.
Schedule
Friday, March 1
9:00 AM
Dr. Leachman / Welcome, Introduction of Speakers and Program
9:10 AM
Dr. Curiel-Lewandrowski / Introduction to Augmented Dermatology
9:30 AM
Dr. Tschandl / What Dermatologist Should Know About Machine Learning and Practice Implementation
9:40 AM
Dr. Malvehy / Melanoma Detection by New Generation 2-D and 3-D Total Body Scanning
9:50 AM
All faculty / Panel Discussion on AI and Total Body Imaging
10:00 AM
Dr. Rigel / Spectroscopic and Electrical Impedance Devices: Learning Lessons and Current State of Implementation
10:20 AM
Witkowski / Reflectance Confocal Microscopy: Optical Biopsies That Augment Everyday Skin Cancer Workflow
10:30 AM
Dr. Tkaczyk / Emerging Imaging Modalities for Melanoma Diagnosis and Surveillance
10:40 AM
Dr. Chen / Can New Technologies Be Incorporated Into Everyday Dermatology: Apps, TeleMedicine, and Wearables?
10:50 AM
All faculty / Panel Discussion On The Most Promising New Gadgets
11:05 AM
Dr. Gerami / Diagnostic and Predictive Molecular Tests
11:15 AM
Dr. Ferris / Primary Care Based Skin Cancer Screening
11:25 AM
Dr. Leachman / War on Melanoma, Oregon & Beyond
11:35 AM
Dr. Swetter / Melanoma Disparities in California: Targeting High Risk Populations Through Community Engagement
Event Details
  • Date
    Friday, March 1
  • Time
    9:00 AM - 12:00 PM
  • Location
    Room 204A
  • CME Credits
    3.00
  • Type
Directors/Co-Directors
Speakers
  • Alexander Witkowski, MD, PhD
  • Clara N. Curiel-Lewandrowski, MD, FAAD
  • Darrell S. Rigel, MD, FAAD
  • Eric Robert Tkaczyk, MD, PhD, FAAD - Handout 1, Handout 2
  • Joseph Malvehy, MD - Handout
  • Laura K. Ferris, MD, PhD, FAAD
  • Pedram Gerami, MD, FAAD - Handout
  • Philipp Tschandl, MD
  • Suephy C. Chen, MD, FAAD - Handout
  • Susan M. Swetter, MD, FAAD - Handout